Lyle P. Luedeman Form 3 RTI SURGICAL / Lyle P. Luedeman ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Luedeman Lyle P.

(Last) (First) (Middle)

11621 RESEARCH CIRCLE

(Street)

ALACHUA FL 32615

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/13/2016

3. Issuer Name and Ticker or Trading Symbol
RTI SURGICAL, INC. [ RTIX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
Vice President Human Resources

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,021(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase Common Stock, $.001 par value per share	(2)	02/25/2024	Common Stock, par value $.001	12,000	3.78	D
Option to purchase Common Stock, $.001 par value per share	(3)	02/17/2025	Common Stock, par value $.001	15,000	5.23	D
Option to purchase Common Stock, $.001 par value per share	(4)	02/24/2026	Common Stock, par value $.001	12,903	3.31	D

Explanation of Responses:

1. This Restricted Stock Award will become vested as to 1,007 shares on each of 2/24/2017, 2/24/2018 and 2/24/2019.

2. Consist of 3,000 fully vested and exercisable options and 9,000 unvested options that will vest and become exercisable as to 3,000 shares on each of 2/25/2017, 2/25/2018 and 2/25/2019.

3. Consist of 3,000 fully vested and exercisable options and 12,000 unvested options that will vest and become exercisable as to 3,000 shares on each of 2/17/2017, 2/17/2018, 2/17/2019 and 2/17/2020.

4. This option will become exercisable as to 2,581 shares on each of 2/24/2017, 2/24/2018, 2/24/2019 and 2,580 shares on each of 2/24/2020 and 2/24/2021.

	/s/Lyle P. Luedeman	12/21/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.